Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Theravance Biopharma - 11 Year Stock Price History | TBPH

Historical daily share price chart and data for Theravance Biopharma since 2014 adjusted for splits and dividends. The latest closing stock price for Theravance Biopharma as of June 04, 2025 is 11.01.
  • The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
  • The Theravance Biopharma 52-week high stock price is 11.82, which is 7.4% above the current share price.
  • The Theravance Biopharma 52-week low stock price is 7.44, which is 32.4% below the current share price.
  • The average Theravance Biopharma stock price for the last 52 weeks is 9.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Theravance Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 9.3151 9.2800 11.1500 8.3200 11.0100 17.00%
2024 9.0101 11.5900 11.5900 7.6600 9.4100 -16.28%
2023 10.3301 10.9700 11.9200 8.3800 11.2400 0.18%
2022 9.7236 12.2800 12.9600 8.3300 11.2200 1.54%
2021 14.3495 17.5300 22.4600 6.7700 11.0500 -37.82%
2020 21.8099 24.6700 31.2100 14.7850 17.7700 -31.36%
2019 21.2692 26.1800 28.1500 15.6000 25.8900 1.17%
2018 26.3454 28.0700 35.0700 22.0600 25.5900 -8.25%
2017 33.1766 32.5000 42.5600 23.8800 27.8900 -12.52%
2016 24.2707 16.2400 38.5800 13.3500 31.8800 94.51%
2015 15.5786 14.7000 21.7300 10.8800 16.3900 9.85%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.556B $0.064B
Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.665B 32.14
Zoetis (ZTS) United States $75.819B 28.29
Daiichi Sankyo, - (DSNKY) Japan $49.559B 25.21
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Sandoz Group AG (SDZNY) Switzerland $22.493B 0.00
Merck (MKKGY) Germany $16.918B 12.40
Summit Therapeutics (SMMT) United States $15.314B 0.00
United Therapeutics (UTHR) United States $14.624B 12.94
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.371B 42.37
Orion OYJ (ORINY) Finland $9.913B 26.81
IPSEN (IPSEY) France $9.890B 0.00
Corcept Therapeutics (CORT) United States $7.371B 59.92
Stevanato Group S.p.A (STVN) Italy $6.599B 40.35
Madrigal Pharmaceuticals (MDGL) United States $6.315B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.734B 0.00
Ionis Pharmaceuticals (IONS) United States $5.532B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.900B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.038B 10.65
Crinetics Pharmaceuticals (CRNX) United States $3.006B 0.00
Hypermarcas (HYPMY) Brazil $2.829B 18.61
BioCryst Pharmaceuticals (BCRX) United States $2.342B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.335B 12.63
NewAmsterdam Pharma (NAMS) Netherlands $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.784B 0.00
Indivior (INDV) United States $1.748B 7.41
Dyne Therapeutics (DYN) United States $1.508B 0.00
Evotec AG (EVO) Germany $1.431B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Guardian Pharmacy Services (GRDN) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.081B 21.62
Harrow (HROW) United States $1.076B 0.00
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Ardelyx (ARDX) United States $0.940B 0.00
Collegium Pharmaceutical (COLL) United States $0.939B 5.07
Avadel Pharmaceuticals (AVDL) Ireland $0.912B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.727B 0.00
KalVista Pharmaceuticals (KALV) United States $0.664B 0.00
Xencor (XNCR) United States $0.651B 0.00
AleAnna (ANNA) United States $0.631B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Relay Therapeutics (RLAY) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.552B 0.00
Bioventus (BVS) United States $0.547B 13.88
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Tourmaline Bio (TRML) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Oruka Therapeutics (ORKA) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Altimmune (ALT) United States $0.440B 0.00
Verve Therapeutics (VERV) United States $0.431B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 9.85
Organogenesis (ORGO) United States $0.356B 0.00
Aquestive Therapeutics (AQST) United States $0.316B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.296B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.86
MediWound (MDWD) Israel $0.233B 0.00
ProKidney (PROK) United States $0.228B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.179B 0.00
Journey Medical (DERM) United States $0.168B 0.00
OmniAb (OABI) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Larimar Therapeutics (LRMR) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Liminatus Pharma (LIMN) $0.138B 0.00
Wellgistics Health (WGRX) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.089B 14.61
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 64.22
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Lyra Therapeutics (LYRA) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.14
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00